Evidence map›Paper›PMID 30787368›Full record

ArticleScientific reports2019

A Haemophilus sp. dominates the microbiota of sputum from UK adults with non-severe community acquired pneumonia and chronic lung disease.

Daniel G Wootton, Michael J Cox, Gregory B Gloor, David Litt, Katja Hoschler, Esther German, Joanne Court, Odiri Eneje, Lynne Keogan, Laura Macfarlane and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. The relationship betweenFrontiers in medicine · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Daniel G WoottonInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK. dwootton@liverpool.ac.uk.ORCID 0000-0002-5903-3881
Michael J CoxSection of Genomic Medicine, National Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0002-4002-1506
Gregory B GloorDepartments of Biochemistry and Applied Mathematics, University of Western Ontario, Ontario, ON, Canada.ORCID 0000-0001-5803-3380
David LittRespiratory and Vaccine Preventable Bacteria Reference Unit, National Infection Service, Public Health England, London, UK.ORCID 0000-0002-9215-0553
Katja HoschlerVirus Reference Department, National Infection Service, Public Health England, London, UK.
Esther GermanDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Joanne CourtDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Odiri EnejeDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Lynne KeoganDepartment of Respiratory Research, Aintree University Hospital NHS Foundation Trust, Liverpool, UK.
Laura MacfarlaneDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Sarah WilksDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Peter J DiggleCHICAS, Lancaster University Medical School, Lancaster University, Lancaster, UK.
Mark WoodheadDepartment of Respiratory Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Miriam F MoffattSection of Genomic Medicine, National Heart and Lung Institute, Imperial College London, London, UK.
William O C CooksonSection of Genomic Medicine, National Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0001-9551-4677
Stephen B GordonDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Liverpool School of Tropical Medicine · GBImperial College London · GBUniversity of Liverpool · GBPublic Health England · GBLancaster University · GBManchester Academic Health Science Centre · GBWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The demographics and comorbidities of patients with community acquired pneumonia (CAP) vary enormously but stratified treatment is difficult because aetiological studies have failed to comprehensively identify the pathogens. Our aim was to describe the bacterial microbiota of CAP and relate these to clinical characteristics in order to inform future trials of treatment stratified by co-morbidity. CAP patients were prospectively recruited at two UK hospitals. We used 16S rRNA gene sequencing to identify the dominant bacteria in sputum and compositional data analysis to determine associations with patient characteristics. We analysed sputum samples from 77 patients and found a Streptococcus sp. and a Haemophilus sp. were the most relatively abundant pathogens. The Haemophilus sp. was more likely to be dominant in patients with pre-existing lung disease, and its relative abundance was associated with qPCR levels of Haemophilus influenzae. The most abundant Streptococcus sp. was associated with qPCR levels of Streptococcus pneumoniae but dominance could not be predicted from clinical characteristics. These data suggest chronic lung disease influences the microbiota of sputum in patients with CAP. This finding could inform a trial of stratifying empirical CAP antibiotics to target Haemophilus spp. in addition to Streptococcus spp. in those with chronic lung disease.

Indexed as

Chronic DiseaseCommunity-Acquired InfectionsHealthcare-Associated PneumoniaLung DiseasesAgedFemaleHaemophilus influenzaeHumansLungMaleMicrobiotaMiddle AgedRNA, Ribosomal, 16SSputumStreptococcus pneumoniaeUnited KingdomRNA, Ribosomal, 16S

Identifiers

PMID30787368
PMCPMC6382935
OpenAlexW2918088677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.